Celltrion Healthcare Co., Ltd.
091990
Kedudukan dalam Saham
#2142
Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on... Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on the development, manufacturing, and distribution of biosimilar and biological therapeutic agents for patients around the globe. Its product lineup includes Remsima, a monoclonal antibody biosimilar used to treat various inflammatory and autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, Crohn's disease in both adults and children, psoriasis, and psoriatic arthritis. Another significant offering, Truxima, targets conditions like lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, microscopic polyangiitis, and rheumatoid arthritis. Herzuma is prescribed for metastatic breast cancer, early-stage breast cancer, and metastatic gastric cancer. Additionally, Remsima SC provides a treatment option for rheumatoid arthritis. Founded in 1999, the enterprise was initially known as Nexol, Inc. before rebranding to Celltrion Healthcare Co., Ltd. in March 2009. The firm's corporate headquarters are situated in Incheon, South Korea.
Harga Saham
$57.75
Disegerakkan terakhir: 2024-01-11
Modal Pasaran
$9.42B
Perubahan (1 hari)
-0.25%
Perubahan (1 tahun)
0.00%
Negara
KR
Perdagangan Celltrion Healthcare Co., Ltd. (091990)
Kategori
Healthcare
Sejarah dividen untuk Celltrion Healthcare Co., Ltd. (091990)
Celltrion Healthcare Co., Ltd. (simbol saham: 091990) telah membuat sejumlah 1 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): $130.00
Hasil dividen (TTM): 0.0017
Jumlah semua dividen (disesuaikan untuk pemecahan saham): $130.00
Hasil dividen (TTM): 0.0017
Pembayaran dividen untuk Celltrion Healthcare Co., Ltd. (091990) dari 2022 hingga 2026
Pembayaran dividen tahunan
| Tahun | Dividen (diselaraskan untuk pemecahan saham) | Ubah |
|---|---|---|
| 2026 (TTM) | $130.00 | 0.00% |
| 2022 | $130.00 | 0.00% |
Senarai semua pembayaran dividen
| Tahun | Dividen | Ubah |
|---|---|---|
| 2026 (TTM) | $135.20 | 0.00% |
| 2022 | $135.20 | 0.00% |
Pembayaran dividen untuk syarikat serupa atau pesaing
| Syarikat | Jumlah pembayaran dividen | Negara |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 0.00% |
NL
|
|
| 30.00% |
BE
|
